Specifically, the CRISPR study demonstrated a significant effect of MCM4 on tumor cells, evident in both the overall analysis and individual cell line assessments across all cancer types, with all gene effects registering below 0 and a mean effect skewed leftward of -1 (Fig. 3A, Fig. S4A). The gene discussed is MCM4; the disease is neoplasm.